Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2009

01-12-2009 | Review

Chemical Colitis Due to Glutaraldehyde: Case Series and Review of the Literature

Authors: Emel Ahishali, Oya Uygur-Bayramiçli, Can Dolapçioğlu, Reşat Dabak, Alperen Mengi, Aygün Işik, Elvan Ermiş

Published in: Digestive Diseases and Sciences | Issue 12/2009

Login to get access

Abstract

Chemical colitis can occur as a result of accidental contamination of endoscopes or by intentional/accidental administration of enemas containing various chemicals. We present three cases of glutaraldehyde induced colitis and review the cases in the literature. Glutaraldehyde-induced colitis presents clinically with severe abdominal pain, bloody and mucoid diarrhea, rectal bleeding, and tenesmus 48–72 h after colonoscopy. Endoscopic findings are nonspecific and mimic ischemic colitis, inflammatory bowel disease, and infectious colitis. The timing of symptoms and the knowledge that glutaraldehyde is a chemical irritant to colonic mucosa is important for the diagnosis. The treatment is mainly supportive but sometimes necessitates mesalamine, prednisolone, or metronidazole and the resolution is rapid. In endoscopy units, strict adherence to published disinfection protocols is very important and the cleaning, rinsing and drying protocols also deserve the same attention.
Literature
1.
go back to reference Stein BL, Lamoureux E, Miller M, Vasilevsky CA, Julien L, Gordon PH. Glutaraldehyde-induced colitis. Can J Surg. 2001;44:113–116.PubMed Stein BL, Lamoureux E, Miller M, Vasilevsky CA, Julien L, Gordon PH. Glutaraldehyde-induced colitis. Can J Surg. 2001;44:113–116.PubMed
3.
go back to reference Ballantyne B, Jordan SL. Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures. J Appl Toxicol. 2001;21:131–151. doi:10.1002/jat.741.CrossRefPubMed Ballantyne B, Jordan SL. Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures. J Appl Toxicol. 2001;21:131–151. doi:10.​1002/​jat.​741.CrossRefPubMed
5.
8.
go back to reference Jonas G, Mahoney A, Murray J, Getrler S. Chemical colitis due to endoscope cleaning solutions: a mimic of pseudomembranous colitis. Gastroenterology. 1988;95:1403–1408.PubMed Jonas G, Mahoney A, Murray J, Getrler S. Chemical colitis due to endoscope cleaning solutions: a mimic of pseudomembranous colitis. Gastroenterology. 1988;95:1403–1408.PubMed
10.
go back to reference Babb RR, Paaso BT. Glutaraldehyde proctitis. West J Med. 1995;163:477–478.PubMed Babb RR, Paaso BT. Glutaraldehyde proctitis. West J Med. 1995;163:477–478.PubMed
11.
go back to reference Coche G, Izet T, Descombes P, et al. Chemical colitis caused by glutaraldehyde. J Radiol. 1997;78:215–217.PubMed Coche G, Izet T, Descombes P, et al. Chemical colitis caused by glutaraldehyde. J Radiol. 1997;78:215–217.PubMed
12.
go back to reference Birnbaum BA, Gordon RB, Jacops JE. Glutaraldehyde colitis: radiologic findings. Radiology. 1995;195:131–134.PubMed Birnbaum BA, Gordon RB, Jacops JE. Glutaraldehyde colitis: radiologic findings. Radiology. 1995;195:131–134.PubMed
13.
go back to reference Rozen P, Somjen GJ, Baratz M, Kimel R, Arber N, Gilat T. Endoscope-induced colitis: description, probable cause by glutaraldehyde, and prevention. Gastrointest Endosc. 1994;40:547–553.PubMed Rozen P, Somjen GJ, Baratz M, Kimel R, Arber N, Gilat T. Endoscope-induced colitis: description, probable cause by glutaraldehyde, and prevention. Gastrointest Endosc. 1994;40:547–553.PubMed
Metadata
Title
Chemical Colitis Due to Glutaraldehyde: Case Series and Review of the Literature
Authors
Emel Ahishali
Oya Uygur-Bayramiçli
Can Dolapçioğlu
Reşat Dabak
Alperen Mengi
Aygün Işik
Elvan Ermiş
Publication date
01-12-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0630-2

Other articles of this Issue 12/2009

Digestive Diseases and Sciences 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine